The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
Timothy S. Johnson
Melvyn Round Kidney Research Laboratories
Sheffield Kidney Institute
Northern General Hospital
University of Sheffield
UK
Name/email consistency: high
- Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. Johnson, T.S., Fisher, M., Haylor, J.L., Hau, Z., Skill, N.J., Jones, R., Saint, R., Coutts, I., Vickers, M.E., El Nahas, A.M., Griffin, M. J. Am. Soc. Nephrol. (2007)
- Tissue transglutaminase: a mediator and predictor of chronic allograft nephropathy?. Johnson, T.S., Abo-Zenah, H., Skill, J.N., Bex, S., Wild, G., Brown, C.B., Griffin, M., El Nahas, A.M. Transplantation (2004)
- Tissue transglutaminase and the progression of human renal scarring. Johnson, T.S., El-Koraie, A.F., Skill, N.J., Baddour, N.M., El Nahas, A.M., Njloma, M., Adam, A.G., Griffin, M. J. Am. Soc. Nephrol. (2003)
- Matrix metalloproteinases and their inhibitions in experimental renal scarring. Johnson, T.S., Haylor, J.L., Thomas, G.L., Fisher, M., El Nahas, A.M. Exp. Nephrol. (2002)
- The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. Johnson, T.S., Griffin, M., Thomas, G.L., Skill, J., Cox, A., Yang, B., Nicholas, B., Birckbichler, P.J., Muchaneta-Kubara, C., Meguid El Nahas, A. J. Clin. Invest. (1997)
